Talk:PerkinElmer

message: The Perkin-Elmer article could be improved by bringing it into line with its relationship with NASA and the history of the Hubble Telescope. 
:I would like to see the article improved, by adding in the various companies it bought or merged with over time. Wjhonson 16:33, 13 September 2006 (UTC)
thread_title: Improve by...

message: This description is accurate according to our company press releases: 
PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The Company reported revenue of approximately $2.2 billion in 2013, has about 7,600 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.
This description is not accurate: 
PerkinElmer, Inc. is an American multinational technology corporation, focused in the business areas of human and environmental health, including environmental analysis, food and consumer product safety, medical imaging, drug discovery, diagnostics, biotechnology, industrial applications, and life science research. PerkinElmer produces analytical instruments, genetic testing and diagnostic tools, medical imaging components, software, instruments, and consumables for multiple end markets.  — Preceding unsigned comment added by 165.88.14.90 (talk) 18:52, 7 March 2014 (UTC)
replies: text: Wikipedia is not a vehicle for advertising, the current opening statement is an objective description of the company. The version you propose is overly promotional, does not come close to abiding by the Policy on Neutral Point of View, and may be a case of Conflict of Interest.  18:59, 7 March 2014 (UTC)
thread_title: Improve by...

message: Ok, not directly related - but it's a question that's been annoying me for quite a while. Does anyone know why those Labsupply companies (almost) never show the price for their articles on their webpages??Lukas 07:52, 22 June 2006 (UTC)
thread_title: Labsupply co

message: This is Jennifer Werner from PerkinElmer. A group of us have been looking over this entry and saw that some items were out-of-date. We respect that it is improper for any of us to make these edits to the entry ourselves. So we hope you’ll consider these suggestions in the spirit intended—to improve the overall quality of this entry based on objective data. I figure this is the easiest way to outline the out-of-date items in order:
Summary Box Description
Industry:
Current text: Health Sciences, Fluid Sciences, Optoelectronics, Biotechnology.
Suggested text: Human Health, Environmental Analysis, Medical Imaging, Drug Discovery, Diagnostics, Biotechnology, Specialty Lighting and Sensors.
Support/rationale: PKI has redefined and extended its business since the likely basis for this description was incorporated into Wikipedia. [Source: http://yahoo.brand.edgar-online.com/displayfilinginfo.aspx?FilingID=7088810-8787-67490&type=sect&TabIndex=2&companyid=10493&ppu=%252fdefault.aspx%253fcik%253d31791]
Products:
Current text: Analytical instruments, Optoelectronics, Genetic Screening tools, Medical Imaging equipment, Life & Analytical Science software and instruments 
Suggested text: Analytical instruments, genetic testing and diagnostic tools, medical imaging equipment, software, instruments and consumables for life sciences
Support/rationale: PKI divested, merged, or otherwise expanded parts of this business [Source: http://yahoo.brand.edgar-online.com/displayfilinginfo.aspx?FilingID=6441403-8398-73910&type=sect&TabIndex=2&companyid=10493&ppu=%252fdefault.aspx%253fcik%253d31791]
Revenue:
Current text: ^ $2.0 billion USD (2009)
Suggested text: $1.8 billion USD (2009)
Support/rationale: Revenue figure is incorrect [Source: 
http://www.wikinvest.com/stock/PerkinElmer_%28PKI%29/Filing/10-K/2008/F2933770
http://online.barrons.com/article/SB126843791004361209.html
Employees: 
Current text: ~9000 (2010)
Suggested text: 8,800 (2010)
Support/rationale: Employee number is incorrect 
[Source: http://www.wikinvest.com/stock/Agilent_Technologies_%28A%29/Filing/10-K/2009/F46735936]
Lead Summary
Current text: PerkinElmer is part of the S&P 500 index and operates in 125 countries. As of 2005, it has a market capitalization of ~3.0 billion.
Suggested text: PerkinElmer is part of the S&P 500 index and operates in 150 countries. As of 2010, it has a market capitalization of ~3.0 billion. 
Support/Rationale: The posted data is five years old and PerkinElmer operates in 150 countries. [Source : http://yahoo.brand.edgar-online.com/displayfilinginfo.aspx?FilingID=6441403-8398-73910&type=sect&TabIndex=2&companyid=10493&ppu=%252fdefault.aspx%253fcik%253d31791]
Focus Areas:
Current text: 
•	Optoelectronics 
Suggested substitution:
•	Imaging, Lighting, Sensors
Support/rationale: PKI’s Optoelectronics business has since been redefined as Imaging, Lighting and Sensors and therefore calls for clearer specification. [Source: http://investing.businessweek.com/research/stocks/private/snapshot.asp?privcapId=4204104] 
Misc:
Correction: the word ‘formally’ is misspelled in the ‘History’ section.  —Preceding unsigned comment added by JVWerner (talk • contribs) 17:30, 20 July 2010 (UTC)
replies: text: I incorporated these updates. The only one I skipped was "formally" because it's not clear to me (without spending more time) where this correction is meant. Thank you for supplying these reasonable suggestions with respectable supporting links. — ¾-10 02:55, 22 July 2010 (UTC)
thread_title:  PerkinElmer Wikipedia Page: Suggestions for Changes 

message: This is Jennifer Werner from PerkinElmer. Thank you for the recent updates. While the Summary Box is now current with PerkinElmer’s industries and products, the intro copy still references Optoelectronics and Fluid Sciences, which are no longer how that part of our business is defined.
The current text states: “PerkinElmer, Inc. (NYSE: PKI) is an American multinational technology corporation, focused in the business areas of: Life and Analytical Sciences, Optoelectronics, and Fluid Sciences. PerkinElmer's Life and Analytical Sciences division engineers and manufactures drug research and development tools, chemical, environmental, food and consumer product monitoring instruments, medical imaging devices, genetic screening tools and software for cellular imaging & analysis. Their Optoelectronics division designs and builds digital imaging and specialty lighting equipment.”
We suggest the following: “PerkinElmer, Inc. (NYSE: PKI) is an American multinational technology corporation, focused in the business areas of human and environmental health, including Environmental Analysis, Food and Consumer Product Safety, Medical Imaging, Drug Discovery, Diagnostics, Biotechnology, Industrial Applications and Life Science Research. PerkinElmer produces analytical instruments, genetic testing and diagnostic tools, medical imaging components, software, instruments and consumables for multiple end markets.”
Support/rationale: PKI has redefined and extended its business since the likely basis for this description was incorporated into Wikipedia. [Source: http://yahoo.brand.edgar-online.com/displayfilinginfo.aspx?FilingID=7088810-8787-67490&type=sect&TabIndex=2&companyid=10493&ppu=%252fdefault.aspx%253fcik%253d31791]  —Preceding unsigned comment added by JVWerner (talk • contribs) 17:13, 13 August 2010 (UTC)
replies: text: I incorporated the updates. Thanks. — ¾-10 21:55, 14 August 2010 (UTC)
replies: text: I would like to learn more about the history of the PerkinElmer Environmental Analysis business (and products) and how that results in instruments for end markets (particularly in governments seeking to gather environmental data for decisionmaking). MaynardClark (talk) 13:38, 28 May 2017 (UTC)
thread_title:  Suggestions for changes to PerkinElmer entry 

message: This is Mary Tran from PerkinElmer. Thank you for the recent updates. In reviewing the history section of the company’s entry, we noticed several points were not complete. To improve the overall quality of this entry and provide a more complete account, we have outlined the following pieces with suggestions for improvement:
Current text: EG&G began in 1931; It was started by two MIT professors, Harold Edgerton and Kenneth Germeshausen in a Boston garage. The company was originally incorporated in 1947 as EG&G.
Suggested text:  EG&G began in 1931; It was started by a professor at MIT, Harold Edgerton, and MIT students Kenneth Germeshausen and Herbert Grier in a Boston garage.  In 1946, co-founder of EG&G, Harold Edgerton accepted the Medal of Freedom from the United States War Department for his efforts to develop strobe lamp technology powerful enough for aerial nighttime photography.  During the following 30 years, EG&G advanced the field of electro-optics in unmatched research and development with more than 50 exclusive patents.
Source:  http://biz.yahoo.com/ic/107/107665.html
Current text: Perkin-Elmer was founded in 1937 by Richard Perkin and Charles Elmer as an optical design and consulting company. In 1944, Perkin-Elmer entered the analytical-instruments business and in the early 1990s, PerkinElmer partnered with Cetus Corporation (and later Hoffmann-La Roche) to pioneer the polymerase chain reaction (PCR) equipment industry.  
Suggested  additional text:   In the 1980s, PerkinElmer's joint venture with MDS Sciex resulted in the first ICP-MS instrument for commercial applications.  Then later in 2000, PerkinElmer partnered with GE Medical Systems as its exclusive supplier of digital X-Ray detectors for advanced medical imaging to establish digital as a healthcare standard.
Source 1: http://pubs.acs.org/cen/coverstory/88/8813cover4d.html
Source 2: http://www.atp.nist.gov/gems/ge-95-01-0152.htm
Current text: In 1992 they merged with Applied Biosystems.   In 1997 they merged with PerSeptive Biosystems. On July 14, 1999 the new analytical instruments maker PerkinElmer cut 350 jobs, or 12%, in its cost reduction reorganization.
Suggested text: In 1992 they merged with Applied Biosystems.   In 1997 they merged with PerSeptive Biosystems. The acquisition brought instruments for mass spectrometry, peptide synthesis, and oligonucleotide synthesis.  In 1998 they acquired Lumen Technologies, adding to its portfolio short arc Xenon lighting, Mercury Xenon lighting, flash lamps, metal halide lamps, Hg capillary, quartz xenon electroform reflectors and aerospace qualified lighting. On July 14, 1999 the new analytical instruments maker PerkinElmer cut 350 jobs, or 12%, in its cost reduction reorganization.
Source: http://www.thefreelibrary.com/EG%26G+to+Acquire+Perkin-Elmer's+Analytical+Instruments+Division+For...-a054029771
Suggested additional text:  Its 2000 acquisition of NEN Life Science Products provided customers with a world-class line of radioactive reagents and instruments for genomic, proteomic, and drug discovery research; and its 2001 acquisition of Packard BioScience extended its capabilities in automation, liquid handling and sample preparation. Also in 2001, PerkinElmer acquired Analytical Automation Specialists, Inc., a leading supplier of Laboratory Information Management Systems (LIMS), which allowed PerkinElmer to provide a valuable informatics tool for improving laboratory productivity. Following in 2005, PerkinElmer expanded its capabilities in its existing photonics portfolio with the acquisition of Elcos AG, adding leading-edge light emitting diode (LED) solutions.
Source 1: http://www.highbeam.com/doc/1G1-62663694.html
Source 2: http://findarticles.com/p/articles/mi_m0EIN/is_2001_Sept_27/ai_78682272/
Source 3: http://www.scientific-computing.com/features/feature.php?feature_id=121
Source 4: http://www.chemeurope.com/news/e/43408/
Current text: In 2006 PerkinElmer sold off the Fluid Sciences division for approximately $400M, the aim on the sell off was to increase the strategic focus on its higher-growth health sciences and photonic markets. Following on from the sell off a number of leading /dynamic small businesses were acquired, these included Spectral Genomics, Improvision, Evotec-Technologies, Euroscreen, ViaCell and Avalon Instruments.
Suggested text: In 2006 PerkinElmer sold off the Fluid Sciences division for approximately $400M, the aim on the sell off was to increase the strategic focus on its higher-growth health sciences and photonic markets. Following on from the sell off a number of leading /dynamic small businesses were acquired, these included Spectral Genomics, Improvision, Evotec-Technologies, Euroscreen, ViaCell and Avalon Instruments.  The purchase of Evotec Technologies strengthened the company’s high throughput and advanced cellular screening offerings. The brand "Evotec-Technologies" remains the property of Evotec, the former owner company. PerkinElmer had a license to use the brand till the end of year 2007. The acquisition of Avalon Instruments grew PerkinElmer’s molecular spectroscopy product portfolio. Lastly in 2006, PerkinElmer capped off the year with the purchase of Euroscreen Products, the developer of AequeoScreenTM, a novel luminescence platform for screening G-protein-coupled receptors (GPCR), one of the largest classes of drug targets
Source  1: http://www.labtechnologist.com/Products/PerkinElmer-buys-Evotec-Technologies
Source 2: http://www.chemie.de/news/e/60773/
Current Text: PerkinElmer has continued to expand its interest in medicine with the acquisitions of clinical laboratories:
In July 2006, it acquired NTD Labs located on Long Island, New York. The laboratory specializes in prenatal screening during the first trimester of pregnancy. 
In October 2007, it purchased ViaCell, Inc. with its offices in Boston and cord blood storage facility in Kentucky near Cincinnati. The company was renamed ViaCord. 
Suggested Text: PerkinElmer has continued to expand its interest in medicine with the acquisitions of clinical laboratories and services, including NTD Labs, Pediatrix, Signature Genomics, Surendra, SYM-BIO and VisEn Medical.
In July 2006, it acquired NTD Labs located on Long Island, New York. The laboratory specializes in prenatal screening during the first trimester of pregnancy. 
In October 2007, it purchased ViaCell, Inc. with its offices in Boston and cord blood storage facility in Kentucky near Cincinnati. The company was renamed ViaCord. 
Source NTD Labs (part of current entry): http://en.wikipedia.org/wiki/PerkinElmer
Source Pediatrix (part of current entry): http://en.wikipedia.org/wiki/PerkinElmer
Source Signature Genomics: http://www.genomeweb.com/arrays/perkinelmer-acquire-cyto-array-firm-signature-genomic-labs-90m-bolster-testing-s
Source Surendra: http://www.genengnews.com/gen-news-highlights/perkinelmer-makes-two-acquisitions-to-pad-diagnostics-business-in-emerging-markets/62254783/
Source SYM-BIO: http://www.genengnews.com/gen-news-highlights/perkinelmer-makes-two-acquisitions-to-pad-diagnostics-business-in-emerging-markets/62254783/
Source VisEn Medical: http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=25922
Suggested additional text: In 2007, PerkinElmer launched EcoAnalytix®, a revolutionary problem-solving initiative that addresses the global imperatives of food and consumer product safety, water quality, and sustainable energy development to create a healthy and safe environment.  The program provides complete solutions for water quality, food quality, and bio-fuels development, including instrumentation, application method development, product and application support, training, and industry knowledge-sharing.  
Source: http://www.highbeam.com/doc/1G1-200158813.html
Suggested additional text: PerkinElmer has also continued expansion of its service offerings through acquisition. In 2007 the company acquired LabMetrix Technologies and Improvision Ltd., a UK-based leader in cellular imaging software and integrated hardware solutions used in life science research.
Source: http://www.laboratorytalk.com/news/pki/pki326.html
Suggested additional text to the end of the current entry: In the forth quarter of 2008, PerkinElmer underwent a strategic re-alignment of its businesses to further the company’s focus on improving human and environmental health.  This alignment reflects PerkinElmer’s strategic mission around actively creating better outcomes that help improve the health and safety of people and the environment.  To reflect the company’s new strategic focus on human and environmental health, PerkinElmer, Inc. changed their tagline from “Precisely” to “For the Better.”  
Source: 
http://www.boston.com/business/healthcare/articles/2008/11/11/perkinelmer_to_restructure_into_2_units_next_year/
http://www.prweb.com/releases/environmental_health/human_health/prweb1598994.htm
http://www.photonics.com/Article.aspx?AID=35642
Suggested additional text: During 2008 and 2009, PerkinElmer expanded its analytical capabilities with the acquisition of Arnel Inc., a recognized leader in custom engineered solutions for gas chromatography applications in the petrochemical, food and beverage, and industrial hygiene markets; and Analytica of Branford, a pioneer and leader in mass spectrometry (MS) and ion source technology. 
Source 1: http://www.gainerstoday.com/Recommendations-PKI
Source 2: http://www.tradingmarkets.com/.site/news/Stock%20News/2310514/
Source 3: http://www.topdevicecompanies.com/2009/09/medical-devices-perkinelmer-buys-china-symbio-surendra.html
Suggested additional text:  In September of 2009 PerkinElmer acquired the genetic screening business of Surendra Genetic Labs, Pvt Ltd., a leading laboratory in India that focuses on fetal, maternal and newborn health; and SYM-BIO, a leading diagnostics company based in China, which allows them to expand their regional and worldwide diagnostics offerings.
Source 1: http://www.genengnews.com/gen-news-highlights/perkinelmer-makes-two-acquisitions-to-pad-diagnostics-business-in-emerging-markets/62254783/
Source 2: http://pubs.acs.org/cen/news/87/i37/8737notw2.html
Source 3: http://www.allbusiness.com/company-activities-management/company-structures-ownership/12857675-1.html
Source 4: http://www.tradingmarkets.com/.site/news/Stock%20News/2519562/
Suggested additional text: In February of 2010, PerkinElmer expanded its diagnostic capabilities further, with the opening of the PerkinElmer Health Screening Laboratory in Chennai, India. The laboratory uses advanced technology to diagnose common and serious health issues in expecting mothers and babies in India, including prenatal testing for Down Syndrome and other genetic disorders, maternal testing for pre-eclampsia, diabetes, thyroid disorders, and infectious disease, and newborn testing for potentially fatal inherited and metabolic disorders.
In conjunction with the opening of the laboratory, the company also announced its collaboration with MediScan Systems, led by founder Dr. S. Suresh, a leading Fetal Medicine Specialist and sonologist in India. MediScan is certified by Dr. Kypros Nicolaides, director of the Fetal Medicine Foundation UK, as the first official Fetal Medicine Foundation Training Center in India.
Source 1: http://www.medicalnewstoday.com/articles/179621.php
Source 2: http://www.ddw-online.com/industrynews/420349/perkinelmer_launches_health_screening_lab.html
Suggested additional text: In April of 2010, PerkinElmer acquired Signature Genomic Laboratories, LLC (Signature). Founded in 2003 by Lisa G. Shaffer, PhD and Bassem A. Bejjani, MD, Signature performs diagnostic cytogenetic testing of chromosome abnormalities in individuals with unexplained physical and developmental disabilities. Signature's microarray diagnostic technology is available for both pre-natal and post-natal identification of DNA alterations associated with genetic disease. More recently, Signature launched a suite of services for the diagnosis of patients with leukemia. 
Source 1: http://www.genomeweb.com/arrays/perkinelmer-acquire-cyto-array-firm-signature-genomic-labs-90m-bolster-testing-s
Source 2: http://www.massdevice.com/news/perkinelmer-puts-its-signature-buyout-genetic-testing-company
Source 3: http://www.streetinsider.com/Mergers+and+Acquisitions/PerkinElmer+%28PKI%29+Announces+Acquisition+of+Signature+Genomic+Labs/5527909.html
Suggested additional text: PerkinElmer acquired VisEn Medical, Inc. in August of 2010. This acquisition enables the company to enhance its cellular imaging business, by expanding its technologies and capabilities downstream into preclinical research undertaken in academic institutes and pharmaceutical companies.  
Source: http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=25922
Suggested additional text: Also in August 2010, PerkinElmer announced its definitive agreement to sell its Illumination and Detection Solutions (IDS) business to Veritas Capital Fund III, L.P. for approximately $500 million in cash.  IDS includes approximately 3,000 employees and 14 manufacturing facilities worldwide and is a leading global provider of custom-designed specialty lighting and sensor components, subsystems and integrated solutions to major OEMs serving a number of applications within various health, environmental, and security segments. The business is expected to generate revenue of approximately $300 million in 2010.  The divestiture of the IDS business reduces the complexity of the company and frees up capital to reinvest in more attractive Human Health and Environmental Health end markets.  The transaction is expected to close by the end of 2010.
Source: http://www.genengnews.com/gen-news-highlights/perkinelmer-sells-illumination-and-detection-solutions-business-to-veritas-for-500m/81243863/  —Preceding unsigned comment added by Tranmar (talk • contribs) 17:18, 27 October 2010 (UTC)
replies: text:  Update for Wikipedians: I never did incorporate this batch of updates yet, because it was going to require some time and effort which didn't make the bar of my to-do triage. I think it would be good to incorporate these updates to whatever extent they are NPOV (I didn't scrutinize details yet). I'll plan on knocking this out sometime if no one beats me to it. I also feel that PerkinElmer is justified in editing the WP article about them, but I realize the large COI potential and that plenty of other Wikipedians would probably scream shrilly about it. I don't have the answer to that other than to kick the can down the road and say that the conversation about corporations and institutions editing the WP articles about them will need to continue, and in my opinion it has some value (because it supplies person-hours of "usually pretty decent" content building, which are a scarce resource that has value to our volunteer project), as long as the users always clearly identify themselves and don't try to own the article in any way. (An example of how to do it responsibly is seen here on this page.) Besides which, we shouldn't kid ourselves: corporations are going to edit one way or another—either via aboveboard channels (if we provide such), or via stealthier means (if we don't). Some Wikipedians would tell me I'm treading a slippery slope with this thinking (opening Pandora's box? Playing with fire? Insert metaphor here), but it turns out that all of life is lived on a slippery slope. The trick to success is finessing and managing the balance and footing. Regards, — ¾-10 16:24, 17 April 2011 (UTC)
thread_title:  PerkinElmer Wikipedia Page: Suggestions for Changes